Aurora, Colo. June 22, 2022—A recent CBS Denver Channel 4 news story highlighted Foresight Diagnostics among several companies driving healthcare innovation in Colorado.
Foresight’s new state-of-the-art CLIA laboratory is located in the expanding Fitzsimons Innovation Community, adjacent to the Anschutz Medical Campus in Aurora. The Fitzsimons campus houses more than eighty companies and is already providing a $10 billion annual economic impact to Colorado.
Foresight’s mission is to develop technologies capable of detecting cancer up to 200 days earlier than current detection methods. Their highly sensitive minimal residual disease (MRD) platform, PhasED-Seq, can detect trace amounts of cancer DNA in the blood, enabling patients to receive treatment sooner and improve their odds of survival.
To learn more about Foresight Diagnostics and the growth of healthcare innovation in Colorado, see the Channel 4 story here.
